Ambu A/S (LON:0MJF)

Market Cap	3.04B
Revenue (ttm)	654.25M
Net Income (ttm)	41.49M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	73.20
Forward PE	35.86
Dividend	0.04 (0.04%)
Ex-Dividend Date	Dec 5, 2024

Volume	101,162
Average Volume	47,516
Open	96.00
Previous Close	95.74
Day's Range	95.85 - 98.13
52-Week Range	90.85 - 154.65
Beta	1.26
RSI	46.51
Earnings Date	Aug 22, 2025

About Ambu A/S

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,196
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0MJF

Financial Performance

In 2024, Ambu A/S's revenue was 5.39 billion, an increase of 12.90% compared to the previous year's 4.78 billion. Earnings were 235.00 million, an increase of 39.88%.

Financial numbers in DKK